45
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1168700
ICTA provides clinical research, pharmacoepidemiology, clinical trials, and expanded access to APIs ,diagnostics, and medical devices.
- Christophe Clément: Director Business Development
About the Company
ICTA is a privately-held international CRO with 32 years of clinical R&D, pharmaco-epidemiology, expanded access programs for APIs, cell therapies, diagnostics, and medical devices experience. ICTA has international operations throughout Western/Eastern Europe and the USA that offer full clinical research or "a la carte" services
in traditional and adaptive clinical trials from Early Phase to Late Phase across a broad range of therapeutic areas. ICTA is one of the first few CROs to be able to design and effectively conduct Bayesian and adaptive clinical trials, including seamless studies, due to its active participation in an international academic network and secure information system (I-SIT platform).
